Home › Stocks › SAGE › All Fund Holders
SAGE — SAGE THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 43 · Reported value held: $206.76M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2025 | 4.55M | $41.45M | 0.00% | Reduce |
| Vanguard Group history | Q2 2025 | 3.27M | $29.78M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2025 | 1.92M | $17.49M | 0.01% | Reduce |
| Balyasny Asset Management history | Q2 2025 | 1.52M | $13.85M | 0.02% | Add |
| Geode Capital Management history | Q2 2025 | 1.36M | $12.37M | 0.00% | Add |
| Millennium Management history | Q2 2025 | 1.16M | $10.55M | 0.01% | Add |
| Marshall Wace history | Q2 2025 | 1.15M | $10.47M | 0.01% | Reduce |
| Renaissance Technologies history | Q2 2025 | 1.11M | $10.15M | 0.01% | Add |
| AQR Capital Management history | Q2 2025 | 861.37K | $7.86M | 0.01% | Reduce |
| Norges Bank Investment Management history | Q4 2023 | 292.29K | $6.33M | 0.00% | Reduce |
| Soros Fund Management history | Q1 2024 | 275.00K | $5.15M | 0.11% | New |
| Morgan Stanley history | Q2 2025 | 529.38K | $4.83M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2025 | 519.11K | $4.73M | 0.00% | Add |
| Casdin Capital history | Q2 2023 | 90.00K | $4.23M | 0.37% | New |
| Northern Trust Corp history | Q2 2025 | 462.58K | $4.22M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2025 | 458.25K | $4.18M | 0.00% | Add |
| Two Sigma Investments history | Q2 2025 | 268.01K | $2.44M | 0.01% | Reduce |
| Deutsche Bank AG history | Q2 2025 | 215.91K | $1.97M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2025 | 201.54K | $1.84M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2025 | 200.33K | $1.83M | 0.00% | Add |
| BNY Mellon history | Q2 2025 | 183.01K | $1.67M | 0.00% | Add |
| Bank of America Corp history | Q2 2025 | 145.80K | $1.33M | 0.00% | Reduce |
| Franklin Resources history | Q2 2025 | 144.92K | $1.32M | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2025 | 132.91K | $1.21M | 0.00% | Add |
| CPP Investments history | Q1 2024 | 63.30K | $1.19M | 0.00% | Hold |
| UBS Group AG history | Q2 2025 | 88.33K | $805.60K | 0.00% | Add |
| Baillie Gifford & Co history | Q2 2024 | 63.33K | $687.80K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2025 | 47.85K | $436.38K | 0.00% | Reduce |
| Wellington Management Group history | Q2 2024 | 39.65K | $430.55K | 0.00% | Reduce |
| Farallon Capital Management history | Q2 2025 | 42.80K | $390.34K | 0.00% | Hold |
| Prudential Financial history | Q3 2024 | 50.37K | $363.67K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2025 | 37.03K | $337.74K | 0.00% | Add |
| Principal Global Investors history | Q1 2024 | 13.98K | $261.91K | 0.00% | Add |
| Manulife Financial history | Q2 2025 | 20.88K | $190.43K | 0.00% | Add |
| Amundi US history | Q4 2024 | 28.33K | $165.71K | 0.00% | New |
| Janus Henderson Group history | Q4 2024 | 25.89K | $140.47K | 0.00% | Hold |
| Legal & General Investment Management America history | Q2 2025 | 5.17K | $47.20K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2025 | 4.13K | $37.70K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2025 | 1.53K | $13.96K | 0.00% | Add |
| Arrowstreet Capital history | Q2 2023 | 85.07K | $4.00K | 0.01% | New |
| Point72 Asset Management history | Q1 2025 | 79 | $627 | 0.00% | New |
| T. Rowe Price Associates history | Q2 2025 | 43.76K | $400 | 0.00% | Add |
| Lazard Asset Management history | Q2 2025 | 13.23K | $120 | 0.00% | New |